204
K. Ramig et al. / Tetrahedron: Asymmetry 23 (2012) 201–204
6. Ramig, K. Synthesis 2002, 2627–2631.
with R1 = 0.0711, wR2 = 0.2305 for all data (1479 independent
reflections) and 247 parameters; Flack parameter x = 0.01(9).
CCDC 852346 contains the supplementary crystallographic data
for this paper. These data can be obtained free of charge from The
7. Doyle, T. R.; Vogl, O. J. Am. Chem. Soc. 1989, 111, 8510–8511.
8. Crassous, J.; Jiang, Z.; Schurig, V.; Polavarapu, P. Tetrahedron: Asymmetry 2004,
15, 1995–2001.
9. (a) Rozov, L. A.; Ramig, K. Tetrahedron Lett. 1994, 35, 4501–4504; (b) Ramig, K.;
Brockunier, L.; Rafalko, P. W.; Rozov, L. A. Angew. Chem., Int. Ed. Engl. 1995, 34,
222–223; (c) Rozov, L. A.; Rafalko, P. W.; Evans, S. M.; Brockunier, L.; Ramig, K. J.
Org. Chem. 1995, 60, 1319–1325.
10. Aboul-Enein, H. Y.; Bojarski, J.; Szymura-Oleksiak, J. Biomed. Chromatogra.
2000, 14, 213–218.
11. Meinwald, J.; Thompson, W. R.; Pearson, D. L.; Koenig, W. A.; Runge, T.;
Francke, W. Science 1991, 251, 560–561.
Role of the funding source
12. Olejniczak, A.; Katrusiak, A.; Metrangola, P.; Resnati, G. J. Fluorine Chem. 2009,
130, 248–253; Podsiadlo, M.; Katrusiak, A. Acta Cryst. 2007, B63, 903–911.
13. Hamilton, W. Acta Cryst. 1965, 18, 502–510.
The Professional Staff Congress of the City University of New
York, which funded this work, had no role in study design; in the
collection, analysis, and interpretation of data; in the writing of
the report; or in the decision to submit the manuscript for
publication.
14. Koenig, W. A. Gas Chromatographic Enantiomer Separation with Modified
Cyclodextrins; Huethig: Heidelberg, 1992. p. 126; Another report has
appeared describing the analytical separation of the enantiomers of 5,
without reference to Koenig’s earlier work: Grosenick, H.; Schurig, V.;
Costante, J.; Collet, A. Tetrahedron: Asymmetry 1995, 6, 87–88.
15. Costante, J.; Ehlinger, N.; Perrin, M.; Collet, A. Enantiomer 1996, 1, 377–386;
Costante-Crassous, J.; Marrone, T. J.; Briggs, J. M.; McCammon, J. A.; Collet, A. J.
Am. Chem. Soc. 1997, 119, 3818–3823; Costante, J.; Hecht, L.; Polavarapu, P. L.;
Collet, A.; Barron, L. D. Angew. Chem., Int. Ed. Engl. 1997, 36, 885–887.
16. Rozov, L. A.; Rafalko, P. W.; Evans, S. M.; Brockunier, L.; Ramig, K. J. Org. Chem.
1995, 62, 6094.
17. See footnote 28 in Ref. 9c, and Schurig, V.; Grosenick, H.; Juza, M. Rec. Trav.
Chim. Pays-Bas 1995, 114, 211–219.
18. Polavarapu, P. L.; Cholli, A. L.; Vernice, G. J. Pharm. Sci. 1993, 82, 791–793.
19. Schurig, V.; Juza, M.; Green, B. S.; Horakh, J.; Simon, A. Angew. Chem., Int. Ed.
1996, 35, 1680–1682.
Acknowledgments
We thank Dr. Gopal Subramaniam of Queens College of CUNY
for recording the NMR spectra and Dr. Cliff Soll of the CUNY Mass
Spectrometry Facility at Hunter College for recording the high-res-
olution mass spectra. We thank Dr. E. Fujita of Brookhaven Na-
tional Laboratory for the use of the Enraf Nonius CAD4
diffractometer for X-ray data collection. The Professional Staff Con-
gress of the City University of New York is acknowledged for finan-
cial support.
20. Polavarapu, P. L.; Cholli, A. L.; Vernice, G. J. Pharm. Sci. 1997, 86, 267. It
appears that the spectroscopic method used was not at fault; rather, the
vials containing the two enantiomers of desflurane had been mistakenly
switched before analysis, and the mistake was not discovered until after
publication.
References
21. Polavarapu, P. L.; Zhao, C.; Ramig, K. Tetrahedron: Asymmetry 1999, 10, 1099–
1106.
1. Halpern, D. F. Fluorinated Inhalation Anesthetics. In Organofluorine Chemistry
Principles and Commercial Applications; Banks, R. E., Smart, B. E., Tatlow, J. C.,
Eds.; Plenum Press: New York, 1994; pp 543–554.
2. (a) Caravella, J. A.; Richards, W. G. Eur. J. Med. Chem. 1995, 30, 727–728; (b)
Martin, J. L.; Meinwald, J.; Radford, P.; Liu, Z.; Graf, M. L. M.; Pohl, L. R. Drug
Metab. Rev. 1995, 27, 179–189; (c) Mather, L. E.; Fryirs, B. L.; Duke, C. C.;
Cousins, M. J. Anesthesiology 2000, 92, 190–196; (d) Cascorbi, H. F.; Morgan, P.
G.; Sedensky, M. M. Halothane’s Potency is Stereospecific. Meeting of the
American Society of Anesthesiologists, 1994, Abstract A440 (see: Anesthesiology
1994, 81 (Suppl.)).
3. Edamura, F. Y.; Larsen, E. R. Preparation of Optically Active Halothane. Abstracts
of Papers, 159th American Chemical Society National Meeting, 1970, Abstract
ORGN 84.
4. Pearson, D. L. The Synthesis of Enantiomerically Pure Inhalational Anesthetics-
Halothane and Enflurane. Ph. D. Dissertation, Cornell University, 1990.
5. Rozov, L. A.; Ramig, K. Chirality 1996, 8, 3–5.
22. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.;
Cheeseman, J. R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. A.;
Nakatsuji, H.; Caricato, M.; Li, X.; Hratchian, H. P.; Izmaylov, A. F.; Bloino, J.;
Zheng, G.; Sonnenberg, J. L.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.;
Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven,
T.; Montgomery, Jr., J. A.; Peralta, J. E.; Ogliaro, F.; Bearpark, M.; Heyd, J. J.;
Brothers, E.; Kudin, K. N.; Staroverov, V. N.; Kobayashi, R.; Normand, J.;
Raghavachari, K.; Rendell, A.; Burant, J. C.; Iyengar, S. S.; Tomasi, J.; Cossi, M.;
Rega, N.; Millam, N. J.; Klene, M.; Knox, J. E.; Cross, J. B.; Bakken, V.; Adamo, C.;
Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.;
Pomelli, C.; Ochterski, J. W.; Martin, R. L.; Morokuma, K.; Zakrzewski, V. G.;
Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Dapprich, S.; Daniels, A. D.; Farkas,
Ö.; Foresman, J. B.; Ortiz, J. V.; Cioslowski, J.; Fox, D. J. 2009, Gaussian, Inc.,
Wallingford CT.